ArticleTrials2021

Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial.

Yan Biao Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.